We are live on ! Find out more
OM icon

Outset Medical

154 hedge funds and large institutions have $1.16B invested in Outset Medical in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more call options, than puts

Call options by funds: $588K | Put options by funds: $236K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

21% more capital invested

Capital invested by funds: $957M → $1.16B (+$201M)

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

0.05% more ownership

Funds ownership: 7.13%7.18% (+0.05%)

5% less funds holding

Funds holding: 162154 (-8)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
154
Holders Change
-8
Holders Change %
-4.94%
% of All Funds
2.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
57
Reduced
51
Closed
25
Calls
$588K
Puts
$236K
Net Calls
+$352K
Net Calls Change
-$60K
Name Holding Trade Value Shares
Change
Change in
Stake
KM
176
Kalos Management
Georgia
-$4.71K -17 Closed
TWA
177
TCI Wealth Advisors
Arizona
-$3K -11 Closed
ASN
178
Advisory Services Network
Georgia
-$239 -1 Closed

OM Hedge Fund Activity: Q2 2023 in Review

154 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2023, worth a combined $1.16B — up 21% from $957M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of OM and 18 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 57 added.

The largest buyer was Millennium Management, adding an estimated $31.4M. The largest seller was Pura Vida Investments, cutting an estimated $7.65M.

  • 154 institutional investors held Outset Medical (OM) as of Q2 2023, down from 162 in Q1 2023.
  • Funds reported $1.16B of Outset Medical stock for Q2 2023, up 21% quarter-over-quarter.
  • 18 funds opened new Outset Medical positions in Q2 2023 and 25 closed out, a net change of -7 holders.
  • The largest Outset Medical buyer in Q2 2023 was Millennium Management, an estimated $31.4M added.
  • The largest Outset Medical seller in Q2 2023 was Pura Vida Investments, an estimated $7.65M sold.

Based on aggregated 13F filings for Q2 2023.